Transcatheter aortic valve replacement (TAVR) has become a standard treatment for the patients with severe aortic stenosis at a high surgical risk1 . Currently, the indications for TAVR have expanded… Click to show full abstract
Transcatheter aortic valve replacement (TAVR) has become a standard treatment for the patients with severe aortic stenosis at a high surgical risk1 . Currently, the indications for TAVR have expanded to lower surgical risk patients based on the positive results of several randomized clinical trials comparing surgical aortic valve replacement (AVR). This article is protected by copyright. All rights reserved.
               
Click one of the above tabs to view related content.